Psychedelics and the treatment of eating disorders: considerations for future research and practice.
J Eat Disord October 22, 2024 DOI: 10.1186/s40337-024-01125-6
Summary
Emerging evidence suggests psychedelic compounds like psilocybin and MDMA show promise in treating eating disorders by helping patients process trauma and shift rigid thought patterns. Clinical trials indicate these substances, when combined with therapy, may reduce anxiety and improve body image while fostering new perspectives on self-worth and emotional healing.
Abstract
Psychedelics and the treatment of eating disorders: considerations for future research and practice.